You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma

 

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

AbstractFullPdf
Jun 2022409427143
Jul 2022260265109
Aug 202219720153
Sep 202217419247
Oct 202218718759
Nov 202216917060
Dec 202213713740
Jan 202315415454
Feb 202314614854
Mar 202311411452
Apr 2023828340
May 202310210447
Jun 202310811044
Jul 202311011041
Aug 202310210738
Sep 202315015147
Oct 202311111244
Nov 202311912055
Dec 202310410657
Jan 2024848760
Feb 202411311346
Mar 202412812972
Total326033271262